|1.||Couchman, John R: 6 articles (02/2015 - 01/2007)|
|2.||Dobra, Katalin: 5 articles (01/2013 - 11/2002)|
|3.||Nomizu, Motoyoshi: 5 articles (01/2013 - 03/2007)|
|4.||Multhaupt, Hinke A B: 4 articles (02/2015 - 01/2007)|
|5.||Karamanos, Nikos K: 4 articles (01/2014 - 11/2002)|
|6.||Rapraeger, Alan C: 4 articles (04/2010 - 06/2003)|
|7.||Tzanakakis, George N: 3 articles (05/2013 - 11/2002)|
|8.||Bertrand, Jessica: 3 articles (03/2013 - 09/2009)|
|9.||Pap, Thomas: 3 articles (03/2013 - 09/2009)|
|10.||Hozumi, Kentaro: 3 articles (01/2013 - 03/2007)|
|1.||Wounds and Injuries (Trauma)
01/01/1993 - "Because changes in syndecan expression enable cells to become more or less responsive to their microenvironment, understanding these regulatory mechanisms can lead to an improved understanding of how cellular behavior is controlled during development and wound repair."
07/01/2009 - "To activate integrin function through syndecans could be a novel therapeutic approach for chronic wound."
03/31/2009 - "Syndecans influence a wide range of physiological processes, but their contribution is most apparent during wound repair. "
03/15/2007 - "These results indicate that the AG73 peptide is a potent syndecan-binding angiogenesis stimulator and may be useful for therapeutic application to treat ischemic injuries."
05/08/1998 - "Thus, syndecans are shed into acute wound fluids, where they can modify the proteolytic balance of the fluid. "
07/01/2010 - "Remarkably, the syndecan-Fc hybrid molecule possesses multiple attractive microbicidal properties: (i) it blocks HIV-1 infection of primary targets including T cells, macrophages, and dendritic cells (DC); (ii) it exhibits a broad range of antiviral activity against primary HIV-1 isolates, multidrug resistant HIV-1 isolates, HIV-2, and simian immunodeficiency virus (SIV); (iii) it prevents transmigration of HIV-1 through human primary genital epithelial cells; (iv) it prevents HIV-1 transfer from dendritic cells to CD4(+) T cells; (v) it is potent when added 2 h prior to addition of HIV-1 to target cells; (vi) it is potent at a low pH; (vii) it blocks HIV-1 infectivity when diluted in genital fluids; and (viii) it prevents herpes simplex virus infection. "
12/01/2008 - "The liver response to infection demonstrated strain-specific compensatory increases of antithrombin and syndecan gene transcription. "
12/01/2005 - "aeruginosa infection of thermal injury and that syndecan 1-neutralizing agents may be effective supplements to current P. "
05/01/2005 - "hermsii and up-regulate the activation markers syndecan I and B7.1 within 16 h of infection. "
09/01/2015 - "Conversely, during the luteal phase there were factors overexpressed (including moesins, syndecans, and integrins, among others) that could play direct or indirect roles in enhancing HIV-1 infection. "
01/01/2011 - "Our study provides new insights into better understanding of the role of syndecans in tumor progression."
08/01/2005 - "Studies in cancer cells suggest that syndecans may also modulate cell viability. "
01/07/2004 - "However, several emerging studies point to critical roles for the syndecans' extracellular protein domains in tumor cell behavior to include cell adhesion and invasion. "
01/01/2015 - "Syndecans are members of the HSPGs family and are highly expressed in various tumor cells. "
01/01/2015 - "Syndecans perform multiple functions during development, damage repair, tumor growth, angiogenesis, and neurogenesis. "
01/01/2013 - "Syndecans in cartilage breakdown and synovial inflammation."
01/01/2010 - "Evidence from null mice suggests that syndecans have roles in postnatal tissue repair, inflammation and tumour progression. "
10/31/2007 - "This review will focus on the molecular and cellular aspects of how syndecans modulate tissue injury and inflammation, and how syndecans affect the outcome of inflammatory diseases in vivo."
10/31/2007 - "Molecular and cellular mechanisms of syndecans in tissue injury and inflammation."
01/01/2007 - "Syndecans in wound healing, inflammation and vascular biology."
07/01/2009 - "The aim of this study is to investigate the expression of bFGF, its receptors (R1 and R2) and syndecans (1-4) in invasive urothelial carcinoma and normal-looking urothelium by Western blotting, RT-PCR, and immunohistochemistry analyses. "
06/01/2011 - "These syndecans may, therefore, have distinct roles in regulating breast carcinoma cell behavior."
07/01/2006 - "Furthermore, the close correlation between syndecan expression and negative ER status raises the possibility of hormonal regulation or more likely an association with an aggressive, ER-negative carcinoma phenotype."
03/01/1992 - "In anaplastic spindle cell carcinomas, syndecan expression was barely detectable. "
03/01/1992 - "Syndecan in carcinomas produced from transformed epithelial cells in nude mice."
|1.||Proteins (Proteins, Gene)
|2.||Membrane Proteins (Integral Membrane Proteins)
|3.||Type C Phospholipases
|1.||Drug Therapy (Chemotherapy)